Neuroinflammation, memory, and depression: new approaches to hippocampal neurogenesis
As one of most common and severe mental disorders, major depressive disorder (MDD) significantly increases the risks of premature death and other medical conditions for patients. Neuroinflammation is the abnormal immune response in the brain, and its correlation with MDD is receiving increasing attention. Neuroinflammation has been reported to be involved in MDD through distinct neurobiological mechanisms, among which the dysregulation of neurogenesis in the dentate gyrus (DG) of the hippocampus (HPC) is receiving increasing attention. The DG of the hippocampus is one of two niches for neurogenesis in the adult mammalian brain, and neurotrophic factors are fundamental regulators of this neurogenesis process. The reported cell types involved in mediating neuroinflammation include microglia, astrocytes, oligodendrocytes, meningeal leukocytes, and peripheral immune cells which selectively penetrate the blood–brain barrier and infiltrate into inflammatory regions. This review summarizes the functions of the hippocampus affected by neuroinflammation during MDD progression and the corresponding influences on the memory of MDD patients and model animals.
Top-30
Journals
|
1
2
3
4
5
6
|
|
|
International Immunopharmacology
6 publications, 3.87%
|
|
|
Journal of Affective Disorders
5 publications, 3.23%
|
|
|
Brain Sciences
5 publications, 3.23%
|
|
|
International Journal of Molecular Sciences
4 publications, 2.58%
|
|
|
Frontiers in Psychiatry
4 publications, 2.58%
|
|
|
Pharmacological Research
3 publications, 1.94%
|
|
|
Brain, Behavior, and Immunity
3 publications, 1.94%
|
|
|
European Journal of Pharmacology
3 publications, 1.94%
|
|
|
Journal of Ethnopharmacology
3 publications, 1.94%
|
|
|
Cells
3 publications, 1.94%
|
|
|
Neuropharmacology
3 publications, 1.94%
|
|
|
Frontiers in Nutrition
3 publications, 1.94%
|
|
|
Neuroscience
2 publications, 1.29%
|
|
|
Biochemical and Biophysical Research Communications
2 publications, 1.29%
|
|
|
Journal of Neuroinflammation
2 publications, 1.29%
|
|
|
Neuroscience Bulletin
2 publications, 1.29%
|
|
|
Frontiers in Pharmacology
2 publications, 1.29%
|
|
|
Journal of Biological Chemistry
2 publications, 1.29%
|
|
|
Redox Biology
2 publications, 1.29%
|
|
|
Metabolic Brain Disease
2 publications, 1.29%
|
|
|
Molecular Neurobiology
2 publications, 1.29%
|
|
|
NeuroToxicology
2 publications, 1.29%
|
|
|
Psychopharmacology
2 publications, 1.29%
|
|
|
Nutritional Neuroscience
2 publications, 1.29%
|
|
|
Behavioural Brain Research
2 publications, 1.29%
|
|
|
Progress in Neuro-Psychopharmacology and Biological Psychiatry
1 publication, 0.65%
|
|
|
Neurochemistry International
1 publication, 0.65%
|
|
|
Journal of Child Psychology and Psychiatry and Allied Disciplines
1 publication, 0.65%
|
|
|
Depression and Anxiety
1 publication, 0.65%
|
|
|
1
2
3
4
5
6
|
Publishers
|
10
20
30
40
50
60
70
|
|
|
Elsevier
65 publications, 41.94%
|
|
|
Springer Nature
32 publications, 20.65%
|
|
|
MDPI
19 publications, 12.26%
|
|
|
Frontiers Media S.A.
13 publications, 8.39%
|
|
|
Wiley
8 publications, 5.16%
|
|
|
Taylor & Francis
5 publications, 3.23%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 1.29%
|
|
|
IMR Press
2 publications, 1.29%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 0.65%
|
|
|
Oxford University Press
1 publication, 0.65%
|
|
|
Association for Computing Machinery (ACM)
1 publication, 0.65%
|
|
|
IMA Press, LLC
1 publication, 0.65%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 0.65%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.65%
|
|
|
Cambridge University Press
1 publication, 0.65%
|
|
|
Eco-Vector LLC
1 publication, 0.65%
|
|
|
SAGE
1 publication, 0.65%
|
|
|
10
20
30
40
50
60
70
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.